Multiplex testing in high risk BRCA1/2-negative families.

被引：0
|
作者：
Esteban, Irene
Bonache, Sandra
Gadea, Neus
Tenes, Ana
Carrasco, Estela
Balmana, Judith
Gutierrez-Enriquez, Sara
Diez, Orland
机构：
[1] Vall dHebron Inst Oncol, Barcelona, Spain
[2] Vall dHebron Inst Oncol, Oncogenet Grp, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Dept Med Oncol, Breast Canc Unit, Barcelona, Spain
[4] Vall dHebron Inst Reserca, Barcelona, Spain
[5] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain
[6] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Oncogenet Grp, E-08193 Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e12557
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12557
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Effect of the Her2 V655I polymorphism on breast cancer risk in BRCA1/2 mutation positive and negative families.
    Rutter, JL
    Chatterjee, N
    Wacholder, S
    Struewing, J
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 421 - 421
  • [32] Participation of Korean families at high risk for hereditary breast and ovarian cancer in BRCA1/2 genetic testing
    Sun, Young
    Kang, Eunyoung
    Baek, Hyunnam
    Jung, Jaehag
    Hwang, Euijun
    Koo, Jauk
    Kim, Eun-Kyu
    Kim, Sung-Won
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (06) : 527 - 532
  • [33] Risk of ovarian cancer in BRCA1 and BRCA2 mutation negative hereditary breast cancer families
    Kauff, ND
    Mitra, N
    Robson, ME
    Hurley, KE
    Chuai, S
    Goldfrank, D
    Wadsworth, E
    Lee, J
    Cigler, T
    Borgen, PI
    Norton, L
    Barakat, RR
    Offit, K
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (18) : 1382 - 1384
  • [34] Completed BRCA1/BRCA1 mutation analysis reveals a low rate of germline mutation in at-risk African-American families.
    Gayol, L
    Basterrechea, H
    Scholl, T
    Perera, E
    Smith, S
    Arena, JF
    Baumbach, L
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 106 - 106
  • [35] BRCA1/2 mutation spectrum and frequencies in Belgian breast/ovarian cancer families.
    Claes, K
    Poppe, B
    Coene, I
    De Paepe, A
    Messiaen, L
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 232 - 232
  • [36] BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts
    Joo-Yeon Lee
    Jisun Kim
    Sung-Won Kim
    Sue K. Park
    Sei Hyun Ahn
    Min Hyuk Lee
    Young Jin Suh
    Dong-Young Noh
    Byung Ho Son
    Young Up Cho
    Sae Byul Lee
    Jong Won Lee
    John L. Hopper
    Joohon Sung
    [J]. Scientific Reports, 8
  • [37] BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts
    Lee, Joo-Yeon
    Kim, Jisun
    Kim, Sung-Won
    Park, Sue K.
    Ahn, Sei Hyun
    Lee, Min Hyuk
    Suh, Young Jin
    Noh, Dong-Young
    Son, Byung Ho
    Cho, Young Up
    Lee, Sae Byul
    Lee, Jong Won
    Hopper, John L.
    Sung, Joohon
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [38] Association of BRCA1 K1183R Polymorphism with Survival in BRCA1/2-Negative Chinese Familial Breast Cancer
    Pei, Renguang
    Wang, Peng
    Zhou, Yunfeng
    Zhang, Juan
    Ouyang, Tao
    Li, Benyao
    Xie, Yuntao
    [J]. CLINICAL LABORATORY, 2014, 60 (01) : 47 - 53
  • [39] Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient
    Kahn, Ryan
    Garcia-Soto, Arlene
    Silva-Smith, Rachel
    Pinto, Andre
    George, Sophia H. L.
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2016, 17 : 93 - 95
  • [40] BRCA1 and BRCA2 genetic test in high risk patients and families: Counselling and management
    Marchina, Eleonora
    Fontana, Maria Grazia
    Speziani, Michela
    Salvi, Alessandro
    Ricca, Giuseppe
    Di Lorenzo, Diego
    Gervasi, Maria
    Caimi, Luigi
    Barlati, Sergio
    [J]. ONCOLOGY REPORTS, 2010, 24 (06) : 1661 - 1667
12345